Asia On The Move: Novo Appoints New China GM
This article was originally published in PharmAsia News
Executive Summary
Novo Nordisk has promoted a VP from Southeast Asia to lead its China operations, amid a flurry of key executive changes at multinational drug makers in China. Top executive changes are also taking place at Abbvie, Nippon Kayaku and UCB in Japan.